SCHEMBL22895

SCHEMBL22895

CN(C)C([NH])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10526116 0.70
SCHEMBL965804 0.70
Dimethylcarbate SCHEMBL1232328 0.67
SCHEMBL6523333 0.67 ALDH1A1 (0.50)
SCHEMBL1925147 0.67 ALDH1A1 (0.50)
SCHEMBL4512673 0.67
SCHEMBL1332099 0.67
SCHEMBL4820393 0.67
SCHEMBL1190178 0.67
SCHEMBL188011 0.67 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4213 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265083-A1 Heterocycle CDK Inhibitors And Their Use Thereof PRELUDE THERAPEUTICS INCORPORATED 2023-08-24 US claimed
US-20230242543-A1 CDK Inhibitors And Their Use As Pharmaceuticals PRELUDE THERAPEUTICS INCORPORATED 2023-08-03 US claimed
WO-2023087632-A1 ANTI-INFLAMMATORY ANALGESIC COMPOUND AND USE THEREOF 江苏新元素医药科技有限公司 2023-05-25 WO claimed
US-20230144528-A1 CDK Inhibitors And Their Use As Pharmaceuticals PRELUDE THERAPEUTICS, INCORPORATED 2023-05-11 US claimed
WO-2023056441-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS INCORPORATED (US) 2023-04-06 WO claimed
CN-114786673-A CDK inhibitors and their use as medicaments 普莱鲁德疗法有限公司 2022-07-22 CN claimed
EP-4028005-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Prelude Therapeutics, Incorporated (US) 2022-07-20 EP claimed
CN-108780273-B Photosensitive colored resin composition, color filter and manufacturing method thereof, and display device DNP精细化工股份有限公司 2022-06-28 CN claimed
CN-114656429-A Anti-inflammatory analgesic compound and application thereof 江苏新元素医药科技有限公司 2022-06-24 CN claimed
WO-2022035799-A1 HETEROCYCLE CDK INHIBITORS AND THEIR USE THEREOF PRELUDE THERAPEUTICS INCORPORATED (US) 2022-02-17 WO claimed
EP-0104671-B1 OXIME DERIVATIVES OF 3-ALKYLOXY OR 3-ALKYLTHIOMETHYL-7-AMINO-THIAZOLYLACETAMIDO-CEPHALOSPORANIC ACID, THEIR PREPARATION, THEIR USE AS MEDICINES AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1990-05-23 EP claimed
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 US claimed
US-4841086-A Process for the preparation of 2-cyano-2-oximino-acetamide derivatives BAYER AKTIENGESELLSCHAFT (DE) 1989-06-20 US claimed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 EP claimed
EP-0206004-A1 E-isomers of N-alpha-(2-cyano-2-alkoxyiminoacetyl)-amino-acid derivatives and peptides BAYER AG (DE) 1986-12-30 EP claimed
US-4263037-A 5-Cyano-2,3-dihydrobenzofurans useful as herbicides FISONS LIMITED (GB) 1981-04-21 US claimed
US-4248788-A INTERMEDIATES TO CINNAMOYLPIPERAZINES AND -HOMOPIPERAZINES DELALANDE S.A. (FR) 1981-02-03 US claimed
EP-0007719-A2 Cyanbenzofuran derivatives, processes for their preparation and their use in herbicidal compositions; cyanobenzene, benzodioxepine, benzodioxaphosphepine and benzodioxathiepine derivatives FBC LIMITED (GB) 1980-02-06 EP claimed
US-4178442-A ANTIANGOROUS ACTIVITY DELALANDE S. A. (FR) 1979-12-11 US claimed
US-3992405-A ESPECIALLY FOR DYEING POLYACRYLIC FIBERS BAYER AKTIENGESELLSCHAFT (DT) 1976-11-16 US claimed